AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...

First dosing of Tacrolimus Inhalation Powder initiates development program for direct-to-lung delivery of a Thin Film Freezing dry-powder product for prevention of lung transplant rejection Phase 1 ...

Tampa, FL. CoreRx, an integrated contract development and manufacturing organization supporting the international pharmaceutical and biotechnology industries, has further enhanced its offering by ...

According to the CDC, around 1.3 million emergency department visits each year are due to adverse drug events, and 350,000 patients each year are hospitalized after emergency visits for the same ...

With Vator Splash Health coming up soon, we’ve been focusing on different aspects of the healthtech space, including the companies that have raised the most money and how quickly the space itself has ...

Phase 1 repeated dosing of Voriconazole Inhalation Powder of up to 80 mg/dose in healthy subjects for direct-to-lung delivery of voriconazole for Invasive Pulmonary Aspergillosis AUSTIN, ...